Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

MYLOTARG Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for MYLOTARG

Identify potential brand extensions & biosimilar entrants

University Hospital HeidelbergPhase 2
National Center for Tumor Diseases, HeidelbergPhase 2
Hematologics, IncPhase 2

See all MYLOTARG clinical trials

Recent Litigation for MYLOTARG

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Human Genome Sciences Inc. v. Immunex Corp.2007-11-30
PDL Biopharma Inc. v. Alexion Pharmaceuticals Inc.2007-03-16

See all MYLOTARG litigation

Patent Text Search: US Patents for MYLOTARG

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.